Woollard, Peter
GlaxoSmithKline (United Kingdom)
3 papers on CoChatORCID 0000-0002-7654-6902
Most cited papers
- Verified
An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people
Nelson, M. R., Wegmann, D., Ehm, M. G., Kessner, D., St. Jean, P., Verzilli, C., Shen, J., Tang, Z., Bacanu, S.-A., Fraser, D., et al. (2012) · Science
Genomics and Rare DiseasesGenetic Associations and Epidemiology
Cited by 647
- Verified
Broadening the horizon – level 2.5 of the HUPO-PSI format for molecular interactions
Kerrien, S., Orchard, S., Montecchi-Palazzi, L., Aranda, B., Quinn, A. F., Vinod, N., Bader, G. D., Xenarios, I., Wojcik, J., Sherman, D., et al. (2007) · BMC Biology
Bioinformatics and Genomic NetworksAdvanced Proteomics Techniques and Applications
Cited by 266
- Verified
Characterization of a Mycobacterium tuberculosis H37Rv transposon library reveals insertions in 351 ORFs and mutants with altered virulence b bThe precise locations of all of the insertions examined in this study can be found as supplementary data in Microbiology Online (http://mic.sgmjournals.org).
McAdam, R. A., Quan, S., Smith, D. A., Bardarov, S., Betts, J. C., Cook, F. C., Hooker, E. U., Lewis, A. P., Woollard, P., Everett, M. J., et al. (2002) · Microbiology
Tuberculosis Research and EpidemiologyBacterial Genetics and Biotechnology
Cited by 128
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free